Showing results (91-100 of 747) with videos related to
Sort By:
Pageof 75
American Heart Journal|July 3, 2002
Heparin dosing and outcome in acute coronary syndromes: the GUSTO-IIb experience. Global Use of Strategies to Open Occluded Coronary ArteriesIan C Gilchrist, Scott D Berkowitz, Trevor D Thompson, et al.Hypertension (Dallas, Tex. : 1979)|February 21, 2008
Safety of placebo controls in pediatric hypertension trialsP Brian Smith, Jennifer S Li, M Dianne Murphy, et al.Kidney International|June 20, 2008
Negative trials in nephrology: what can we learn?James E Novak, Jula K Inrig, Uptal D Patel, et al.Journal of the American College of Cardiology|March 19, 2004
Meta-analysis of randomized trials of percutaneous transluminal coronary angioplasty versus atherectomy, cutting balloon atherotomy, or laser angioplastyJohn A Bittl, Derek P Chew, Eric J Topol, et al.Clinical Pharmacology and Therapeutics|April 8, 2021
When Are Treatment Blinding and Treatment Standardization Necessary in Real-World Clinical Trials?Jonathan H Watanabe, Gregory E Simon, Michael Horberg, et al.Oral Oncology|December 12, 2018
Cumulative incidence of neck recurrence with increasing depth of invasionJustin R Shinn, C Burton Wood, Juan M Colazo, et al.Journal of Neurosurgery. Spine|August 1, 2015
Cervical disc arthroplasty with PRESTIGE LP disc versus anterior cervical discectomy and fusion: a prospective, multicenter investigational device exemption studyMatthew F Gornet, J Kenneth Burkus, Mark E Shaffrey, et al.Academic Medicine : Journal of the Association of American Medical Colleges|May 2, 2008
Burnout in medical school deans: an uncommon problemSteven G Gabbe, Lynn E Webb, Donald E Moore, et al.Journal of the American Heart Association|May 30, 2014
Racial differences in the prevalence of severe aortic stenosisDevin K Patel, Kelly D Green, Marat Fudim, et al.Therapeutic Innovation & Regulatory Science|January 3, 2022
Why are not There More Bayesian Clinical Trials? Perceived Barriers and Educational Preferences Among Medical Researchers Involved in Drug Development, Jennifer Clark, Natalia Muhlemann, et al.Pageof 75